the Long-term Effects of High-doSe pitavaStatin on Diabetogenicity in Comparison With Atorvastatin in Patients With Metabolic Syndrome (LESS-DM) Randomized Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 08 Feb 2017 Planned primary completion date changed from 1 May 2019 to 30 Nov 2019.
- 08 Feb 2017 Status changed from not yet recruiting to recruiting.
- 25 Oct 2016 New trial record